Source: Marketscreener

Cosmos: Cosmos Health Inc. Launches Sky Premium Life in Albania Through Partnership with Pharma Cell

Cosmos Health Inc. announced the launch of its Sky Premium Life food supplements brand in Albania, in partnership with Pharma Cell, a leading consumer health and medical supplement company that will serve as the distributor in the country. Cosmos Health has secured an initial annual order worth $300,000 and anticipates further scaling its collaboration with Pharma Cell over time. Pharma Cell, based in Tirana, is a fast-growing pharmaceutical company specializing in the import and export of high-quality food supplements. Founded in 2021 by CEO Elvis Punmira, an economist with over 18 years of industry experience, the company builds on a family legacy in the pharma sector dating back to the 1990s. With distribution rights for several international brands, Pharma Cell has rapidly expanded its presence across the country, serving a growing network of pharmacies and healthcare professionals. Cosmos Health Inc. announced the launch of its Sky Premium Life food supplements brand in Albania, in partnership with Pharma Cell, a leading consumer health and medical supplement company that will serve as the distributor in the country. Cosmos Health has secured an initial annual order worth $300,000 and anticipates further scaling its collaboration with Pharma Cell over time. Pharma Cell, based in Tirana, is a fast-growing pharmaceutical company specializing in the import and export of high-quality food supplements. Founded in 2021 by CEO Elvis Punmira, an economist with over 18 years of industry experience, the company builds on a family legacy in the pharma sector dating back to the 1990s. With distribution rights for several international brands, Pharma Cell has rapidly expanded its presence across the country, serving a growing network of pharmacies and healthcare professionals.

Read full article »
Annual Revenue
$25-100M
Employees
100-250
Gregory Siokas's photo - CEO of Cosmos

CEO

Gregory Siokas

CEO Approval Rating

90/100

Read more